We're concerned if the FDA takes maybe a too narrow view regarding the safety and effectiveness data - depending how the final rule ends up - they could take effective products or ingredients off the shelves, they could limit the choice healthcare institutions have.

Brian Sansoni

Categorized in : Company News

We're going to try to answer their questions in great detail as called for, but we believe the FDA already has sufficient data on these products.